Cargando…

Co-stimulatory and immune checkpoint molecules are important in the tumor microenvironment of Hodgkin-like adult T-cell leukemia/lymphoma

Detalles Bibliográficos
Autores principales:	Takeuchi, Mai, Miyoshi, Hiroaki, Semba, Yuichiro, Yamada, Kyohei, Nakashima, Kazutaka, Sato, Kensaku, Furuta, Takuya, Moritsubo, Mayuko, Ogura, Yusuke, Tanaka, Ken, Imamoto, Teppei, Arakawa, Fumiko, Kohno, Kei, Ohshima, Koichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Fondazione Ferrata Storti 2023
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690911/ https://www.ncbi.nlm.nih.gov/pubmed/37439334 http://dx.doi.org/10.3324/haematol.2023.283163

Ejemplares similares

Expression of telomerase reverse transcriptase in peripheral T‐cell lymphoma
por: Arakawa, Fumiko, et al.
Publicado: (2021)

Expression of GLUT1 in Pseudopalisaded and Perivascular Tumor Cells Is an Independent Prognostic Factor for Patients With Glioblastomas
por: Komaki, Satoru, et al.
Publicado: (2019)

Human leukocyte antigen class II expression is a good prognostic factor in adult T-cell leukemia/lymphoma
por: Takeuchi, Mai, et al.
Publicado: (2019)

Prognostic factors for histiocytic and dendritic cell neoplasms
por: Shimono, Joji, et al.
Publicado: (2017)

Epidemiology and secular trends of malignant lymphoma in Japan: Analysis of 9426 cases according to the World Health Organization classification
por: Muto, Reiji, et al.
Publicado: (2018)

COT-9 Prognostic impact of hypercoagulation in glioblastoma and molecular mechanism thereof
por: Negoto, Tetsuya, et al.
Publicado: (2021)

Clinical Features, Pathological Features, and Treatment Outcomes of 22 Patients with Aggressive Adult T-cell Leukemia-lymphoma Treated with a Humanized CCR4 Antibody (Mogamulizumab) at a Single Institution during a 6-year Period (2012-2018)
por: Kawano, Noriaki, et al.
Publicado: (2019)

CS-7 A case of Lymphomatoid granulomatosis with skin, lung, and intracranial lesions due to multicentric development
por: Komaki, Satoru, et al.
Publicado: (2021)

Detection of Tax-specific CTLs in lymph nodes of adult T-cell leukemia/lymphoma patients and its association with Foxp3 positivity of regulatory T-cell function
por: Ichikawa, Ayako, et al.
Publicado: (2017)

CBMS-4 CHROMOSOMAL INSTABILITY IN GLIOMA USING SPECTRAL KARYOTYPING METHOD
por: Negoto, Tetsuya, et al.
Publicado: (2022)

Immune Checkpoint Inhibition in Hodgkin Lymphoma
por: Moy, Ryan H., et al.
Publicado: (2018)

Modulating expression of inhibitory and stimulatory immune ‘checkpoints’ using nanoparticulate-assisted nucleic acid delivery
por: Walters, Adam A, et al.
Publicado: (2021)

Combination of CD47 and signal‐regulatory protein‐α constituting the “don’t eat me signal” is a prognostic factor in diffuse large B‐cell lymphoma
por: Kazama, Ryo, et al.
Publicado: (2020)

Stimulatory effect on the transport mediated by organic anion transporting polypeptide 2B1
por: Ogura, Jiro, et al.
Publicado: (2020)

Immune Checkpoint Blockade for the Treatment of Hodgkin Lymphoma
por: Lin, Adam Yuh, et al.
Publicado: (2022)

Identification of miR-15b as a transformation-related factor in mantle cell lymphoma
por: ARAKAWA, FUMIKO, et al.
Publicado: (2015)

What do we know about co-stimulatory and co-inhibitory immune checkpoint signals in ankylosing spondylitis?
por: Schütz, Christian, et al.
Publicado: (2023)

The Role of Immune Checkpoint Inhibitors in Classical Hodgkin Lymphoma
por: Meti, Nicholas, et al.
Publicado: (2018)

Expression of the immune checkpoint receptor TIGIT in Hodgkin’s lymphoma
por: Li, Wenchao, et al.
Publicado: (2018)

Classical Hodgkin’s Lymphoma in the Era of Immune Checkpoint Inhibition
por: De Re, Valli, et al.
Publicado: (2019)

Checkpoint Inhibitors in Relapsed/Refractory Classical Hodgkin Lymphoma
por: Tarekegn, Kidist, et al.
Publicado: (2021)

Checkpoint CD47 expression in classical Hodgkin lymphoma
por: Gholiha, Alex Reza, et al.
Publicado: (2022)

A Review of Hodgkin Lymphoma in the Era of Checkpoint Inhibitors
por: Schimmoeller, Christopher J, et al.
Publicado: (2023)

Updates in the Role of Checkpoint Inhibitor Immunotherapy in Classical Hodgkin’s Lymphoma
por: Nakhoda, Shazia, et al.
Publicado: (2022)

T-cell co-stimulatory pathways in autoimmunity
por: Goronzy, Jörg J, et al.
Publicado: (2008)

Immunotherapies targeting stimulatory pathways and beyond
por: Marin-Acevedo, Julian A., et al.
Publicado: (2021)

Stimulatory effect of imeglimin on incretin secretion
por: Yingyue, Quan, et al.
Publicado: (2023)

Differences in the immunosurveillance pattern associated with DNA mismatch repair status between right‐sided and left‐sided colorectal cancer
por: Kanno, Hiroki, et al.
Publicado: (2020)

Tumor microenvironment of adult T-cell leukemia/lymphoma
por: Takeuchi, Mai, et al.
Publicado: (2021)

Checkpoint inhibitor immunotherapy during pregnancy for relapsed–refractory Hodgkin lymphoma
por: Evens, Andrew M., et al.
Publicado: (2022)

Tackling the dysregulated immune-checkpoints in classical Hodgkin lymphoma: bidirectional regulations between the microenvironment and Hodgkin/Reed-Sternberg cells
por: Cellini, Alessandro, et al.
Publicado: (2023)

Induction Mechanism of Human Blood CD8(+) T Cell Proliferation and Cytotoxicity by Natural Killer Cell Stimulatory Factor (Interleukin‐12)
por: Nabioullin, Roustem, et al.
Publicado: (1994)

Stimulatory Effect of β-glucans on Immune Cells
por: Kim, Hyung Sook, et al.
Publicado: (2011)

Targeting Co-Stimulatory Pathways in Gene Therapy
por: Huang, Xiaopei, et al.
Publicado: (2011)

The Role of Co-Stimulatory Molecules in Chagas Disease
por: Pinto, Bruna F., et al.
Publicado: (2018)

Co-stimulatory agonists: An insight into the immunotherapy of cancer
por: Pourakbari, Ramin, et al.
Publicado: (2021)

Co-Stimulatory Receptor Signaling in CAR-T Cells
por: Honikel, Mackenzie M., et al.
Publicado: (2022)

Human Alveolar Macrophages Augment Natural Killer Cell Stimulatory Factor (Interleukin‐12)‐inducible Killer Activity from Autologous Blood Lymphocytes
por: Haku, Takashi, et al.
Publicado: (1995)

INHIBITORY AND STIMULATORY EFFECTS OF CONCANAVALIN A ON THE RESPONSE OF MOUSE SPLEEN CELL SUSPENSIONS TO ANTIGEN : II. EVIDENCE FOR SEPARATE STIMULATORY AND INHIBITORY CELLS
por: Dutton, Richard W.
Publicado: (1973)

Lymphocyte-depleted classic Hodgkin lymphoma with primary extranodal disease: Two cases that highlight the combination of immunodeficiency and immune escape in the pathogenesis
por: Tsuyuki, Yuta, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_h4fcaf3msd2ngiiolpt99kq0f7